MSCLF
SATELLOS BIOSCIENCE INC by SATELLOS BIOSCIENCE INC. (MSCLF)
$48
About SATELLOS BIOSCIENCE INC by SATELLOS BIOSCIENCE INC. (MSCLF)
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.
Details
Daily high
$0.48
Daily low
$0.48
Price at open
$0.48
52 Week High
$0.94
52 Week Low
$0.30
Market cap
73.6M
Dividend yield
0.00%
Volume
474
Avg. volume
27,432
P/E ratio
-2.83
SATELLOS BIOSCIENCE INC by SATELLOS BIOSCIENCE INC. News
Details
Daily high
$0.48
Daily low
$0.48
Price at open
$0.48
52 Week High
$0.94
52 Week Low
$0.30
Market cap
73.6M
Dividend yield
0.00%
Volume
474
Avg. volume
27,432
P/E ratio
-2.83